Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

News > All

Total search results: 9859 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 7 8 9 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
InterAx Biotech AG. (5/31/18). "Press Release: InterAx Biotech and Vrije Universiteit Amsterdam Enter a Collaboration to Unlock Novel Chemical Space for Chemokine Therapeutics". Villigen & Amsterdam. 2018-05-31
F-Star Biotechnology Ltd.. (5/30/18). "Press Release: F-Star Announces Early Exercise by Denali Therapeutics of Its Option to Acquire F-star Gamma". Cambridge. 2018-05-30
Five Prime Therapeutics Inc.. (5/30/18). "Press Release: Five Prime Therapeutics Announces Collaboration with Roche to Develop Companion Diagnostics for Targeted Immuno-Oncology Investigational Drug Candidates". South San Francisco, CA. 2018-05-30
CRISPR Therapeutics AG. (5/30/18). "Press Release: CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease". Boston, MA, Zug & Cambridge, MA. 2018-05-30
Agilent Technologies Inc.. (5/30/18). "Press Release: Agilent Technologies to Acquire Assets of Ultra Scientific". Santa Clara, CA. 2018-05-30
Biognosys AG. (5/30/18). "Press Release: Introducing PQ500". 2018-05-30
Centogene AG. (5/29/18). "Press Release: Centogene Announces Agreement with Aldeyra Therapeutics for the Advancement of Novel Therapeutics for Patients with Sjögren-Larsson Syndrome". Rostock. 2018-05-29
Evotec AG. (5/29/18). "Press Release: Evotec and Celgene Expand iPSC Collaboration to Include Additional Cell Lines. $6m Payment to Access Additional Cell Lines". Hamburg. 2018-05-29
High-Tech Gründerfonds Management GmbH. (5/29/18). "Press Release: High-Tech Gründerfonds III- Second Closing Passes All Expectations at 316.5 Million Euro". 2018-05-29
High-Tech Gründerfonds Management GmbH. (5/29/18). "Press Release: Bayer and Boehringer Ingelheim Invest in HTGF III". 2018-05-29
Roche. (5/29/18). "Press Release: Phase III IMpower130 Study Showed Roche’s Tecentriq (atezolizumab) plus Chemotherapy (carboplatin and Abraxane) Helped People with Metastatic Non-squamous NSCLC Live Significantly Longer Compared to Chemotherapy Alone". 2018-05-29
Markes International Ltd.. (5/25/18). "Press Release: Important Notice – Markes International GmbH Office". 2018-05-25
RSP Systems A/S. (5/25/18). "Press Release: Andreas Jenne Has Joined as RSP’s New CEO". 2018-05-25
Medigene AG. (5/24/18). "Press Release: Medigene Announces Capital Increase to Fund Immunotherapy Programs [NOT FOR UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAWS]". Pla 2018-05-24
Lunaphore Technologies S.A.. (5/24/18). "Press Release: Lunaphore and Vitro Sign Collaboration Agreement to Develop ISH Protocols for RNA/DNA Targets". Lausanne & Seville. 2018-05-24
ProBioGen AG. (5/24/18). "Press Release: ProBioGen Announces Further Development Milestone for Use of Its GlymaxX Cancer Cell-killing Enhancement Antibody Technology with Merus N.V.". Berlin. 2018-05-24
Medigene AG. (5/24/18). "Press Release: Medigene Successfully Raises EUR 32.3 Million in Oversubscribed Private Placement [NOT FOR UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICA 2018-05-24
Agilent Technologies Inc.. (5/24/18). "Press Release: Agilent and University of Duisburg-Essen Announce Collaboration Agreement. New Teaching and Research Center for Separation". Santa Clara, CA. 2018-05-24
Messe Stuttgart (Landesmesse Stuttgart GmbH). (5/24/18). "Press Release: T4M Is the New Platform for Medical Engineering in Stuttgart". 2018-05-24
c-LEcta GmbH. (5/24/18). "Press Release: c-LEcta Reports Financial Results of Business Year 2017". 2018-05-24
Vifor Pharma AG. (5/23/18). "Press Release: VFMCRP and Cara Therapeutics to Develop and Commercialise CR845 Injection for Chronic Kidney Disease-associated Pruritus". 2018-05-23
Eurofins Scientific. (5/23/18). "Press Release: Eurofins Announces the Inauguration of Its Newly-upgraded and Expanded State-of-the-Art Food Testing Laboratory in Suzhou, China". 2018-05-23
Apogenix AG. (5/23/18). "Press Release: Apogenix Provides Update on Clinical Development of Asunercept". Heidelberg. 2018-05-23
Evotec AG. (5/23/18). "Press Release: Evotec Expands iPSC Platform with Licence from ID Pharma". Hamburg. 2018-05-23
BioKryo GmbH. (5/22/18). "Press Release: Successful AABB-reaccreditation of BioKryo GmbH". 2018-05-22
Biotecon Diagnostics GmbH. (5/22/18). "Press Release: foodproof RoboPrep Fusion. A Revolutionary High-Throughput Solution for Fully-automated DNA / RNA Extraction and PCR Setup". Potsdam. 2018-05-22
Lonza Group Ltd.. (5/22/18). "Press Release: Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic Non-Parenchymal Cells". Basel. 2018-05-22
Sphingotec GmbH. (5/22/18). "Press Release: Sphingotec Is Adding an Advanced POC Testing Platform to Portfolio". Hennigsdorf & San Diego, CA. 2018-05-22
Bruker Corporation. (5/21/18). "Press Release: Bruker Introduces the New Tracer 5g Handheld XRF Spectrometer". Salt Lake City, UT. 2018-05-21
Evotec AG. (5/21/18). "Press Release: Evotec and Celgene Enter into Strategic Oncology Partnership". Hamburg. 2018-05-21
Nabriva Therapeutics plc. (5/21/18). "Press Release: Nabriva Therapeutics Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia". Dublin & King of Prussia, PA. 2018-05-21
Roche. (5/21/18). "Press Release: Roche’s Hemlibra Reduced Treated Bleeds by 96 Percent Compared to No Prophylaxis in Phase III HAVEN 3 Study in Haemophilia A without Factor VIII Inhibitors". Basel. 2018-05-21
F-Star Biotechnology Ltd.. (5/21/18). "Press Release: F-Star Announces First Patient Dosed in Phase I Clinical Trial of FS118, a First-in-class Immuno-oncology Bispecific Antibody". Cambridge. 2018-05-21
Pierre Fabre S.A.. (5/18/18). "Press Release: Pierre Fabre and Roche Extend Collaboration Agreement on Companion Diagnostic Development". Castres. 2018-05-18
Numares AG. (5/18/18). "Press Release: Numares Initiates Pan-European Multicenter Study of Axinon renalTX-Score on Kidney Allograft Rejection". Regensburg. 2018-05-18
Curetis N.V.. (5/18/18). "Press Release: Curetis Publishes Business and Financial Update for the First Quarter 2018". Amsterdam, Holzgerlingen & San Diego, CA. 2018-05-18
Roche. (5/17/18). "Press Release: Phase III IMpower150 Study Showed Roche’s Tecentriq and Avastin plus Carboplatin and Paclitaxel Helped People with a Specific Type of Metastatic Lung Cancer Live Significantly Longer Compared to Avastin plus Carboplatin 2018-05-17
Roche. (5/17/18). "Press Release: Follow-up Phase III Data Showed Roche’s Alecensa Helped People with ALK-positive Metastatic Non-Small Cell Lung Cancer Live a Median of Almost Three Years Without Their Disease Worsening or Death". Basel. 2018-05-17
InflaRx N.V.. (5/17/18). "Press Release: InflaRx N.V. Reports First Quarter 2018 Financial & Operating Results". Jena. 2018-05-17
Idorsia Ltd.. (5/16/18). "Press Release: Idorsia Initiates MODIFY, a Phase 3 Registration Study to Assess Lucerastat as a Potential New Treatment Option for Patients with Fabry Disease". Allschwil. 2018-05-16
CellCentric Ltd.. (5/15/18). "Press Release: CellCentric Raises $26 Million to Take First-in-Class p300/CBP Inhibitor into the Clinic". 2018-05-15
Global Bioenergies S.A.. (5/15/18). "Press Release: Global Bioenergies Receives Three Additional Fundings from the European Union, further Supporting Its Strategy of Feedstock Diversification". Évry. 2018-05-15
Probiodrug AG. (5/15/18). "Press Release: Probiodrug AG Reports First Quarter 2018 Business Update". Halle (Saale). 2018-05-15
Aldevron LLC. (5/15/18). "Press Release: Aldevron Names Marc Wolff Chief Financial Officer". 2018-05-15
Calyxt, Inc.. (5/15/18). "Press Release: Bayer CropScience, LP Agrees to Settle Lawsuit Filed by Calyxt in Delaware Chancery Court". Minneapolis, MN. 2018-05-15
Medigene AG. (5/15/18). "Press Release: Medigene Reports Outcome of Annual General Meeting". Planegg. 2018-05-15
Merck KGaA. (5/15/18). "Press Release: Merck Reports a Solid Start to 2018". Darmstadt. 2018-05-15
CRISPR Therapeutics AG. (5/15/18). "Press Release: CRISPR Therapeutics Announces Presentations at the ASGCT 21st Annual Meeting". Zug & Cambridge, MA. 2018-05-15
Novartis AG. (5/15/18). "Press Release: Novartis Successfully Completes Acquisition of AveXis, Inc.". Basel. 2018-05-15
Valerius Biopharma AG. (5/14/18). "Press Release: Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars". Somerset, NJ & Basel. 2018-05-14
Medigene AG. (5/14/18). "Press Release: Medigene Significantly Expands TCR Alliance with Bluebird Bio in Cancer Immunotherapy". Planegg. 2018-05-14
Erytech Pharma. (5/14/18). "Press Release: Erytech Strengthens Executive Team with the Appointment of Alex Dusek as VP of Commercial Strategy". Lyon. 2018-05-14
Polyneuron Pharmaceuticals AG. (5/14/18). "Press Release: Polyneuron Pharmaceuticals Completes CHF3.1 Million Seed Financing". Basel. 2018-05-14
Agilent Technologies Inc.. (5/14/18). "Press Release: Agilent Completes Acquisition of Genohm". Santa Clara, CA. 2018-05-14
Affiris AG. (5/14/18). "Press Release: Affiris Announces Encouraging Long-term Data from a Series of First-in-Human Studies Using Affitope PD01A Targeting Oligomeric Alpha-synuclein in Early Parkinsons Disease Patients". Vienna. 2018-05-14
Bruker Corporation. (5/14/18). "Press Release: Bruker Announces Quarterly Dividend". Billerica, MA. 2018-05-14
Acousia Therapeutics GmbH. (5/14/18). "Press Release: Acousia Therapeutics Announces €10 Million Series B Financing to Advance its Hearing Loss Portfolio". Tübingen. 2018-05-14
Brainomix Ltd.. (5/11/18). "Press Release: Brainomix Announces CE Mark Certification for New e-CTA Software". Oxford. 2018-05-11
Arsanis, Inc.. (5/10/18). "Press Release: Arsanis Reports Business Highlights and Financial Results for First Quarter 2018". Waltham, MA & Vienna. 2018-05-10
Pieris Pharmaceuticals, Inc.. (5/10/18). "Press Release: Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update". Boston, MA. 2018-05-10
Memo Therapeutics AG. (5/9/18). "Press Release: Memo Therapeutics AG Closes Series A2 Financing Round of CHF 5 Million to Advance Its Antibody Discovery Programs into Preclinical and Clinical Development". Basel. 2018-05-09
Novartis AG. (5/9/18). "Press Release: Essential Consultants – Novartis Statement". 2018-05-09
Oxford Nanopore Technologies Ltd.. (5/9/18). "Press Release: Oxford Nanopore Announces Favourable Outcome in UK and German Patent Litigation against Pacific Biosciences". 2018-05-09
Bruker Corporation. (5/9/18). "Press Release: 2018 Laukien Prize Winner Announcement". 2018-05-09
Eurofins Scientific. (5/9/18). "Press Release: Eurofins Expands Its Leadership in Biopharmaceutical Services with the Acquisition of PHAST in Germany". 2018-05-09
Centogene AG. (5/9/18). "Press Release: Centogene Announces Drug Development Collaboration with Orphazyme in Neuronopathic Gaucher Disease". Rostock. 2018-05-09
Celonic AG. (5/8/18). "Press Release: Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy". Basel. 2018-05-08
Cevec Pharmaceuticals GmbH. (5/8/18). "Press Release: Cevec and CSL Limited Sign Exclusive License Agreement for Production of Recombinant C1 Esterase Inhibitor Using Cevec’s Proprietary CAPGo Technology". Cologne & Melbourne. 2018-05-08
CRISPR Therapeutics AG. (5/8/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results". Zug & Cambridge, MA. 2018-05-08
CureVac AG. (5/8/18). "Press Release: CureVac Announces New Management Structure. Founder Ingmar Hoerr to Transition to Chairman role; Daniel Menichella to Become CEO". Tübingen. 2018-05-08
DiaSorin S.p.A.. (5/8/18). "Press Release: The DiaSorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018". Saluggia. 2018-05-08
Evotec AG. (5/8/18). "Press Release: Evotec and Carna Biosciences Collaborate on INDiGO Platform". Hamburg. 2018-05-08
InflaRx N.V.. (5/8/18). "Press Release: InflaRx N.V. Announces Closing of Primary and Secondary Offering of Common Shares". Jena. 2018-05-08
Sygnis AG. (5/8/18). "Press Release: Sygnis Completes Acquisition of TGR Biosciences". Heidelberg & Cambridge. 2018-05-08
Greiner Bio-One. (5/8/18). "Press Release: Greiner Bio-One Acquires 3D Cell Culture Technology Assets from Nano3D Biosciences, Inc.". 2018-05-08
Centogene AG. (5/4/18). "Press Release: Centogene Appoints Berndt Modig as New Supervisory Board Member". Rostock. 2018-05-04
Lonza Group Ltd.. (5/4/18). "Press Release: Lonza Reports Positive Start to 2018 with Businesses Along the Healthcare Continuum as Growth Drivers". Basel. 2018-05-04
Lonza Group Ltd.. (5/4/18). "Press Release: Lonza to Invest in Portsmouth, NH (USA) Site, including Mid-Scale Biologics". Portsmouth, NH & Basel. 2018-05-04
Scienion AG. (5/3/18). "Press Release: Revolutionary Milk Analysis Platform Allows for Multiplex Analysis of 100 Antibiotic Residues and Toxins in a Single Test". Berlin & Seraing. 2018-05-03
SmartDyeLivery GmbH. (5/3/18). "Press Release: Nanoparticles for Life-saving Therapies. Stiftung für Technologie, Innovation und Forschung Thüringen (STIFT) and Sparkasse Jena-Saale-Holzland count on an innovative therapeutic concept from Jena". Erfurt 2018-05-03
InflaRx N.V.. (5/3/18). "Press Release: InflaRx N.V. Announces Pricing of Primary and Secondary Offering of Common Shares". Jena. 2018-05-03
Bruker Corporation. (5/3/18). "Press Release: Bruker Reports First Quarter 2018 Financial Results". Billerica, MA. 2018-05-03
Affimed N.V.. (5/3/18). "Press Release: Affimed Introduces ROCK Platform for Tailored Immune Cell Engagers". Heidelberg. 2018-05-03
Qiagen N.V.. (5/2/18). "Press Release: Qiagen Reports Results for First Quarter 2018". Venlo. 2018-05-02
Agilent Technologies Inc.. (5/2/18). "Press Release: Agilent Technologies to Enhance Lab Informatics with Acquisition of Genohm". Santa Clara, CA. 2018-05-02
Evotec AG. (5/2/18). "Press Release: Evotec Expands CRISPR-based Technology Offering with Licence from ERS Genomics". Hamburg. 2018-05-02
MorphoSys AG. (5/2/18). "Press Release: MorphoSys AG Reports First Quarter 2018 Results". Planegg. 2018-05-02
InflaRx N.V.. (5/2/18). "Press Release: InflaRx N.V. Announces Proposed Primary and Secondary Offerings of Common Shares". Jena. 2018-05-02
ERS Genomics Ltd.. (5/2/18). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Evotec". Dublin. 2018-05-02
Neurimmune AG. (5/1/18). "Press Release: Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab". Cambridge, MA & Schlieren. 2018-05-01
Mologic Ltd.. (5/1/18). "Press Release: Mologic Signs Agreements with Medisur and Peripal to Distribute Periplex PoC Diagnostic in Europe". Bedfordshire. 2018-05-01
AdvanceCor GmbH. (5/18). "Press Release: AdvanceCor GmbH Secures Financing for Proof of Concept Patient Studies with a further Financing Round by an Investor Consortium with Occident Group, Bayernkapital, KfW and MIG AG as Lead investors". Munich & Marti 2018-05-01
Addex Therapeutics S.A.. (4/30/18). "Press Release: Addex Reports 2017 Full Year Results and Provides Corporate Update". Geneva. 2018-04-30
Roivant Sciences GmbH. (4/30/18). "Press Release: Datavant Acquires Universal Patient Key and Closes $40M Financing Round". San Francisco, CA. 2018-04-30
Crescendo Biologics Ltd.. (4/30/18). "Press Release: Crescendo Biologics Ltd. Raises $70 Million (€57 Million) in Series B Financing". Cambridge. 2018-04-30
NovellusDx Ltd.. (4/30/18). "Press Release: NovellusDx Announced It Has Completed an Equity Financing of $6 Million". Jerusalem. 2018-04-30
4D Molecular Therapeutics. (4/30/18). "Press Release: 4DMT and Roche Expand Ophthalmology Partnership to Develop and Commercialize Multiple AAV Gene Therapy Products". Emeryville, CA. 2018-04-30
Curetis N.V.. (4/30/18). "Press Release: Curetis Announces Change of the Composition of Its Supervisory Board. Dr. Holger Reithinger Resigns as Member of the Supervisory Board". Amsterdam, San Diego, CA & Holzgerlingen. 2018-04-30
Curetis N.V.. (4/30/18). "Press Release: Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance for 2018". Amsterdam & Holzgerlingen. 2018-04-30
Bruker Corporation. (4/30/18). "Press Release: Bruker Introduces New NMR Technologies and Research Products". Orlando, FL. 2018-04-30
next pagenext page 1 2 3 ... 7 8 9 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top